Pericyazine 2.5mg tablets

Land: Storbritannia

Språk: engelsk

Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiv ingrediens:

Pericyazine

Tilgjengelig fra:

Pharma-z Ltd

ATC-kode:

N05AC01

INN (International Name):

Pericyazine

Dosering :

2.5mg

Legemiddelform:

Oral tablet

Administreringsrute:

Oral

Klasse:

No Controlled Drug Status

Resept typen:

Valid as a prescribable product

Produkt oppsummering:

BNF: 04020100

Informasjon til brukeren

PACKAGE LEAFLET:
INFORMATION FOR THE PATIENT
NEULACTIL
® 2.5MG TABLETS
(pericyazine)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS
INFORMATION IMPORTANT FOR YOU.

Keep this leaflet. You may need to read it again

If you have any further questions, ask your doctor
or pharmacist

This medicine has been prescribed for you. Do not
pass it on to others. It may harm them, even if
their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
The name of your medicine is Neulactil 2.5mg Tablets
but will be referred to as Neulactil throughout this
leaflet.
WHAT IS IN THIS LEAFLET:
1.
What Neulactil is and what it is used for
2.
What you need to know before you take Neulactil
3.
How to take Neulactil
4.
Possible side effects
5.
How to store Neulactil
6.
Contents of the pack and other information
Neulactil belongs to a group of medicines called
‘phenothiazines’. It works by blocking the effect of a
chemical in the brain. It can be used for:

Schizophrenia

The short term treatment of anxiety, agitation and
violent or dangerously impulsive behaviour when
used with other medicines
DO NOT TAKE THIS MEDICINE AND TELL YOUR
DOCTOR IF:

You are allergic (hypersensitive) to pericyazine or
any of the other ingredients in this medicine (listed
in Section 6)

Signs of an allergic reaction include: a rash,
swallowing or breathing problems, swelling of your
lips, face, throat or tongue

You are pregnant, might become pregnant or think
you may be pregnant (see Section below:
‘Pregnancy and breast-feeding’)
Do not take this medicine if any of the above apply to
you. If you are not sure, talk to your doctor or
pharmacist before taking Neulactil.
WARNINGS AND PRECAUTIONS
TALK TO YOUR DOCTOR OR PHARMACIST BEFORE YOU TAKE
THIS MEDICINE IF:
▲ You have heart problems or a family history of
heart problems
▲ You have ever had a str

Preparatomtale

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Pericyazine 2.5mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2.5mg pericyazine.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Pericyazine 2.5mg Tablets: Circular, very pale lime-yellow tablet,
with one
face impressed ‘S171’ just inside the perimeter. Break-line on
reverse.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
a)
In adults with schizophrenia or other psychoses, for the treatment of
symptoms or prevention of relapse.
b)
In anxiety, psychomotor agitation, violent or dangerously impulsive
behaviour. Pericyazine is used as an adjunct to the short-term
management of
these conditions.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_ Severe conditions _
_Indication (a) _
_ _
Adults:_ _Initially 75 mg per day in divided doses. Dosage should be
increased
by 25 mg per day at weekly intervals until the optimum effect is
achieved.
Maintenance therapy would not normally be expected to exceed 300 mg
per
day.
Elderly: _ _Initially 15-30 mg per day in divided doses. If this is
well tolerated
the dosage may be increased if necessary for optimum control of
behaviour.
_Mild or moderate conditions _
_ _
_Indication (b) _
_ _
Adults: Initially 15-30 mg daily, divided into two portions with a
larger dose
being given in the evening.
Elderly: 5-10 mg per day is suggested as a starting dose. It may be
divided so
that a larger portion is given in the evening. Half or quarter the
normal adult
dose may be sufficient for maintenance therapy.
Pericyazine tablets are not recommended for children.
Method of administration
Oral.
Dosage requirement varies with the individual and the severity of the
condition being treated. Initial dosage should be low with progressive
increases until the desired response is obtained, after which dosage
should be
adjusted to maintain control of the symptoms.
4.3
CONTRAINDICATIONS
See use in pregnancy below. Known hypersensitivity to pericyazine or
to any
of the other excipi